| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | ANK | 1.66e-04 | 251 | 61 | 6 | SM00248 | |
| Domain | ANK_REPEAT | 1.73e-04 | 253 | 61 | 6 | PS50088 | |
| Domain | ANK_REP_REGION | 1.77e-04 | 254 | 61 | 6 | PS50297 | |
| Domain | Ankyrin_rpt | 2.09e-04 | 262 | 61 | 6 | IPR002110 | |
| Domain | - | 1.29e-03 | 248 | 61 | 5 | 1.25.40.20 | |
| Domain | Ankyrin_rpt-contain_dom | 1.43e-03 | 254 | 61 | 5 | IPR020683 | |
| Domain | Ank_2 | 5.34e-03 | 215 | 61 | 4 | PF12796 | |
| Domain | Ank | 6.55e-03 | 228 | 61 | 4 | PF00023 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.73e-09 | 123 | 63 | 7 | 26912792 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.70e-07 | 357 | 63 | 8 | 37059091 | |
| Pubmed | A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. | 3.23e-06 | 2 | 63 | 2 | 22387997 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 16899508 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 24805859 | ||
| Pubmed | BCOR-CCNB3 fusion-positive clear cell sarcoma of the kidney. | 3.23e-06 | 2 | 63 | 2 | 31876361 | |
| Pubmed | The nucleoporin Nup153 affects spindle checkpoint activity due to an association with Mad1. | 3.23e-06 | 2 | 63 | 2 | 21327106 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28877060 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 28817404 | ||
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 30064235 | ||
| Pubmed | BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. | 3.23e-06 | 2 | 63 | 2 | 25360585 | |
| Pubmed | YEATS2 RESF1 SUGP2 XPO5 HLTF ZNF318 BCOR ATP2A2 GFI1 NUP153 RAI1 | 4.23e-06 | 1103 | 63 | 11 | 34189442 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 12702765 | ||
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 36791667 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF704 YEATS2 SUGP2 PTPRR MAD1L1 DIP2C RPRD2 LUZP2 ANKMY1 TNRC6C STX17 RAI1 | 1.28e-05 | 1489 | 63 | 12 | 28611215 |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 32840647 | ||
| Pubmed | SERCA2b and 3 play a regulatory role in store-operated calcium entry in human platelets. | 1.93e-05 | 4 | 63 | 2 | 18068335 | |
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.94e-05 | 180 | 63 | 5 | 35198878 | |
| Pubmed | YEATS2 RESF1 SUGP2 CCNB3 SSX2IP ZNF318 BCOR KANK2 PDZRN3 RAI1 | 3.03e-05 | 1116 | 63 | 10 | 31753913 | |
| Pubmed | Exportin-5, a novel karyopherin, mediates nuclear export of double-stranded RNA binding proteins. | 3.22e-05 | 5 | 63 | 2 | 11777942 | |
| Pubmed | 3.49e-05 | 339 | 63 | 6 | 30415952 | ||
| Pubmed | 3.50e-05 | 101 | 63 | 4 | 10997877 | ||
| Pubmed | 3.64e-05 | 102 | 63 | 4 | 10231032 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 20133940 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | 5.31e-05 | 954 | 63 | 9 | 36373674 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 6.49e-05 | 232 | 63 | 5 | 25515538 | |
| Pubmed | 9.58e-05 | 407 | 63 | 6 | 12693553 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | 1.04e-04 | 1294 | 63 | 10 | 30804502 | |
| Pubmed | SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. | 1.09e-04 | 259 | 63 | 5 | 30404004 | |
| Pubmed | Protein phosphatase 1γ isoforms linked interactions in the brain. | 1.55e-04 | 57 | 63 | 3 | 23080069 | |
| Pubmed | 2.14e-04 | 472 | 63 | 6 | 38943005 | ||
| Pubmed | YEATS2 RESF1 SUGP2 NACA RPRD2 ZNF318 TNRC6C BCOR ATP2A2 SOX13 | 2.33e-04 | 1429 | 63 | 10 | 35140242 | |
| Pubmed | 2.70e-04 | 493 | 63 | 6 | 15368895 | ||
| Pubmed | The ubiquitin ligase Ubr4 controls stability of podocin/MEC-2 supercomplexes. | 2.73e-04 | 69 | 63 | 3 | 26792178 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 3.54e-04 | 184 | 63 | 4 | 32908313 | |
| Pubmed | 4.22e-04 | 754 | 63 | 7 | 35906200 | ||
| Pubmed | 4.32e-04 | 17 | 63 | 2 | 22411552 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.94e-04 | 774 | 63 | 7 | 15302935 | |
| Pubmed | Ontogeny and Trophic Factor Sensitivity of Gastrointestinal Projecting Vagal Sensory Cell Types. | 5.41e-04 | 19 | 63 | 2 | 36973009 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 5.55e-04 | 1038 | 63 | 8 | 26673895 | |
| Pubmed | 7.17e-04 | 222 | 63 | 4 | 37071664 | ||
| Pubmed | 7.53e-04 | 225 | 63 | 4 | 12168954 | ||
| Pubmed | 7.63e-04 | 396 | 63 | 5 | 26687479 | ||
| Pubmed | Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases. | 7.97e-04 | 23 | 63 | 2 | 14715245 | |
| Pubmed | 7.97e-04 | 23 | 63 | 2 | 28811219 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 8.34e-04 | 1105 | 63 | 8 | 35748872 | |
| Pubmed | 8.69e-04 | 24 | 63 | 2 | 23063659 | ||
| Pubmed | Hyperactive Wnt signaling changes the developmental potential of embryonic lung endoderm. | 9.43e-04 | 25 | 63 | 2 | 15186480 | |
| Pubmed | 9.87e-04 | 242 | 63 | 4 | 34011540 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 1.04e-03 | 109 | 63 | 3 | 33554859 | |
| Pubmed | 1.10e-03 | 27 | 63 | 2 | 26442671 | ||
| Pubmed | 1.17e-03 | 653 | 63 | 6 | 22586326 | ||
| Pubmed | 1.24e-03 | 116 | 63 | 3 | 30804394 | ||
| Pubmed | Germline deletion of Cdyl causes teratozoospermia and progressive infertility in male mice. | 1.36e-03 | 30 | 63 | 2 | 30850578 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 1.47e-03 | 934 | 63 | 7 | 33916271 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.50e-03 | 271 | 63 | 4 | 32433965 | |
| Pubmed | 1.55e-03 | 32 | 63 | 2 | 33669244 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.75e-03 | 283 | 63 | 4 | 30585729 | |
| Pubmed | 1.75e-03 | 963 | 63 | 7 | 28671696 | ||
| Interaction | B9D2 interactions | 8.69e-08 | 73 | 61 | 6 | int:B9D2 | |
| Interaction | DTX2 interactions | 6.57e-06 | 330 | 61 | 8 | int:DTX2 | |
| Interaction | NUP50 interactions | 8.35e-06 | 341 | 61 | 8 | int:NUP50 | |
| Interaction | CFAP184 interactions | 9.47e-06 | 162 | 61 | 6 | int:CFAP184 | |
| Interaction | KYAT1 interactions | 2.90e-05 | 20 | 61 | 3 | int:KYAT1 | |
| Interaction | SMG7 interactions | 4.89e-05 | 319 | 61 | 7 | int:SMG7 | |
| Interaction | SLX4 interactions | 5.22e-05 | 572 | 61 | 9 | int:SLX4 | |
| GeneFamily | Ankyrin repeat domain containing | 2.08e-04 | 242 | 41 | 5 | 403 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.08e-08 | 152 | 62 | 6 | 621e9b33cd3bb1c7b7d0633069f286b203e3d9c0 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-07 | 183 | 62 | 6 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.12e-07 | 183 | 62 | 6 | 12daaea821e49bc94a01e2496331e92a80d27339 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-07 | 189 | 62 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.65e-07 | 190 | 62 | 6 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.73e-07 | 191 | 62 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-07 | 192 | 62 | 6 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.90e-07 | 193 | 62 | 6 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.27e-07 | 197 | 62 | 6 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.27e-07 | 197 | 62 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.58e-07 | 200 | 62 | 6 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 168 | 62 | 5 | 260c768468dff51888f7a68e5424bb174dbaa759 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-06 | 168 | 62 | 5 | 18d7719a76620d5e5698f9ffd08b4ad4cb7c13f8 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.42e-06 | 174 | 62 | 5 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.55e-06 | 175 | 62 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.55e-06 | 175 | 62 | 5 | c01a15b2084da4a18f8ff3623f44eb9dfe499f10 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.22e-06 | 180 | 62 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-06 | 185 | 62 | 5 | 6712512100ccef456d2e2bd201d0987986c92ac9 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 5.96e-06 | 185 | 62 | 5 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.28e-06 | 187 | 62 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 6.44e-06 | 188 | 62 | 5 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-06 | 189 | 62 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 191 | 62 | 5 | 08042952431ca1a6fd7dfc13f36eb28643979598 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.96e-06 | 191 | 62 | 5 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.14e-06 | 192 | 62 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 7.14e-06 | 192 | 62 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 193 | 62 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.32e-06 | 193 | 62 | 5 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.50e-06 | 194 | 62 | 5 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.50e-06 | 194 | 62 | 5 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.08e-06 | 197 | 62 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.08e-06 | 197 | 62 | 5 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.28e-06 | 198 | 62 | 5 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 8.28e-06 | 198 | 62 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | distal-3-mesenchymal-Myofibroblast|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.49e-06 | 199 | 62 | 5 | 1f20addc0d138fec02ed6ca4c518169c568de263 | |
| ToppCell | distal-2-mesenchymal-Myofibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.49e-06 | 199 | 62 | 5 | b8f3cf5bcfde1066bdb49b14fdc842fe9692a6b7 | |
| ToppCell | distal-mesenchymal-Myofibroblast-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.70e-06 | 200 | 62 | 5 | 069c8949b33ecfdb6da32992002d4060ff6082bc | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.70e-06 | 200 | 62 | 5 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 3dd022e974fec7013ba18f333da63f58fbf2dd7c | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.70e-06 | 200 | 62 | 5 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Acinar_Adenocarcinoma-7|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.26e-05 | 130 | 62 | 4 | 0219d0d5d21df08f816569c7eb34f1bfa095d29a | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.73e-05 | 143 | 62 | 4 | 7a7a9829ba63468c9745904d9e993590051207ab | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 5.41e-05 | 148 | 62 | 4 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-05 | 155 | 62 | 4 | 441fcb6d05364fc6f4973f0b973f1a80b573ce1f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.47e-05 | 155 | 62 | 4 | 59035d792c26d870a8b097939e97fa47859ba68c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_VISp_Hsd11b1_Endou|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.97e-05 | 158 | 62 | 4 | c8af8964a140acb2987e3b4906d72c546108d229 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.05e-05 | 164 | 62 | 4 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.06e-05 | 60 | 62 | 3 | 40f29dfdbb17d39d8e6bb69dc5066fca3cd03308 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.06e-05 | 60 | 62 | 3 | 3a58f7a8e3d8a544286b7a3fe62efac8a0a0bb11 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Slc17a8-Inhibitory_Neuron.Gad1Gad2Slc17a8_Sst.Ncam2_(Interneuron,__GABA/Glutamate_co-releasing?)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.06e-05 | 60 | 62 | 3 | ce13bbda7d105e1cb421790fb50d3b55ba2ed09a | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 168 | 62 | 4 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.04e-05 | 169 | 62 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 170 | 62 | 4 | 50c6c571591aa4b218caefe5778c570c809f567e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 170 | 62 | 4 | 8fe32dcf924d5f6665f7febbc9647d96b1e96f06 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.25e-05 | 170 | 62 | 4 | 3232db50b1a40f861e981a1b9c9073b81af9f832 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.46e-05 | 171 | 62 | 4 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.46e-05 | 171 | 62 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.90e-05 | 173 | 62 | 4 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-04 | 174 | 62 | 4 | f90ca117b729436cf452e2ddcec26ba525c5c13b | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.03e-04 | 175 | 62 | 4 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.08e-04 | 177 | 62 | 4 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | b1db59344c074c7c80169fc2c5cd5fc89f3fe463 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 178 | 62 | 4 | 579cdc14f28b459e200ae2102e0bd4df8a2c0dcb | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.18e-04 | 181 | 62 | 4 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 181 | 62 | 4 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 181 | 62 | 4 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | critical-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.18e-04 | 181 | 62 | 4 | f0d81ae74d3f32979624a94b2ef93774831a7970 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 182 | 62 | 4 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-04 | 182 | 62 | 4 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-04 | 182 | 62 | 4 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 183 | 62 | 4 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 184 | 62 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.25e-04 | 184 | 62 | 4 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-SST-MGE1-3|World / Primary Cells by Cluster | 1.25e-04 | 184 | 62 | 4 | 907ba412166bcb0526c5be0b06a76b6bd37c5a35 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.25e-04 | 184 | 62 | 4 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 185 | 62 | 4 | 7b1c5d99bd7a6e148524029758cee244a17f5d09 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 185 | 62 | 4 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 185 | 62 | 4 | e9033a03d574956cf3ae228740b3166e40a6397f | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 185 | 62 | 4 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 185 | 62 | 4 | e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.28e-04 | 185 | 62 | 4 | 578f12c6b2e33d09598dc8e022a20c8555d1325c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 186 | 62 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 1.34e-04 | 187 | 62 | 4 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 62 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.34e-04 | 187 | 62 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.34e-04 | 187 | 62 | 4 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 188 | 62 | 4 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 188 | 62 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.39e-04 | 189 | 62 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 1.39e-04 | 189 | 62 | 4 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 189 | 62 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.39e-04 | 189 | 62 | 4 | a3cd4c2da4feb9bdcd8957f3e344d095da1367b8 | |
| Disease | schizophrenia, anorexia nervosa | 1.36e-04 | 48 | 61 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | neck circumference | 7.03e-04 | 19 | 61 | 2 | EFO_0011043 | |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 1.13e-03 | 24 | 61 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | malaria | 1.25e-03 | 102 | 61 | 3 | EFO_0001068 | |
| Disease | Bilateral Wilms Tumor | 1.65e-03 | 29 | 61 | 2 | C2930471 | |
| Disease | aortic measurement | 1.82e-03 | 251 | 61 | 4 | EFO_0020865 | |
| Disease | Nephroblastoma | 2.53e-03 | 36 | 61 | 2 | C0027708 | |
| Disease | heart disease (implicated_via_orthology) | 2.82e-03 | 38 | 61 | 2 | DOID:114 (implicated_via_orthology) | |
| Disease | Kidney Neoplasm | 3.12e-03 | 40 | 61 | 2 | C0022665 | |
| Disease | Malignant neoplasm of kidney | 3.93e-03 | 45 | 61 | 2 | C0740457 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SKPSCSLASGLKSMV | 481 | P0C6C1 | |
| STSIKMITGCTKPTA | 1246 | Q8WWZ4 | |
| SPVCMSKLTKSLPAS | 526 | Q9Y2D8 | |
| PATKDSEMCKFSPAD | 1036 | Q6W2J9 | |
| SKMSCRESAPLTPSS | 2396 | Q9Y485 | |
| QTTICGAMSSIKKPT | 306 | Q8WWL7 | |
| CPQSDPLMKASSTSF | 126 | P0C854 | |
| PVASDSSPMGSKTKE | 1116 | Q7Z5J4 | |
| SLVSMCKDLSSPTPS | 901 | Q9UPQ7 | |
| AADASTTSPKPRKSM | 501 | Q9NZL6 | |
| TKSVPSGSEMPAKCD | 276 | P09238 | |
| KMTSPSPSVDADKVS | 86 | Q6TGC4 | |
| DCLIFKATSPSGSKM | 661 | Q9Y6D9 | |
| SASPASEKSMCPSLD | 96 | Q99684 | |
| SSMKPLKCPTSSLSS | 431 | P43220 | |
| KSSSAMTLKTVACAP | 276 | Q5VTL7 | |
| MAQDTCKSKSQVPPS | 111 | Q86UF4 | |
| SKPITMEKASASSCP | 566 | Q8IVL0 | |
| LPSADSCTSPTKMDL | 646 | Q8IVL0 | |
| STVKTKKVTPFPMSC | 1586 | Q13219 | |
| CGPSHSKESMVSPKI | 446 | O95800 | |
| FSPVCDPMDSKASVS | 86 | Q96EY5 | |
| TTATSVCPSPFKMKP | 316 | Q15256 | |
| VYCTPNKPSRTSMSK | 496 | P16615 | |
| ITTKSMAAPPSCGLS | 431 | P56159 | |
| SPKAPCLTTMDTNGK | 331 | Q9Y2E4 | |
| LKMASPSPCTSSFDK | 496 | Q9P2S6 | |
| CSMKHKESPPSNATA | 291 | Q86TE4 | |
| RSKCKKDVFMPPSSS | 181 | O95243 | |
| IKCSFAPMSDDESPT | 831 | Q63ZY3 | |
| MKSNPPRSSLEACKA | 1 | A6NKP2 | |
| ACALTSSVPTTKKKM | 441 | Q14527 | |
| KSSMKLTNLCTSLPS | 3716 | Q8NDH2 | |
| SKASSCTPVPVTMTA | 411 | Q5VT52 | |
| TMPVSSCTPKKKCSI | 1671 | Q6ZTR5 | |
| MECSLQAKPAVPTSK | 146 | P11686 | |
| LPDPSKMETTKSCDS | 731 | Q4G0U5 | |
| KKSVNMTECVPVPSS | 61 | Q6ZN04 | |
| CSMPTASTVKKPFDL | 6 | Q86YR6 | |
| TKGLECSPSTPTMNS | 511 | Q08AM6 | |
| PVAASALCKPASKSM | 861 | Q9HCJ0 | |
| ALSTKTPAPCSEFME | 71 | Q99932 | |
| TCPGGTFTPSMKSTK | 411 | Q13275 | |
| PAVCETISVPKSMST | 556 | Q9HCM1 | |
| MSAKSKGNPSSSCPA | 1 | Q569H4 | |
| SSKESMCSTPAFPVS | 836 | Q68CZ2 | |
| EKTDLTMSTAACPPS | 1971 | P35498 | |
| PSPKTICYMISSLSK | 686 | P48995 | |
| NTSSSPSLKMSSCVP | 306 | Q9UN79 | |
| KEPQMSPSVAASLSC | 1341 | Q7Z2Z1 | |
| KMMEKLTSSCPDLPS | 281 | P56962 | |
| TSSPCPSADIDMKTM | 771 | Q8IX01 | |
| VKMGFPSKTDSPSCE | 406 | Q9HAV4 | |
| CMSEKPGSSVPASSS | 816 | P49790 | |
| TETPCAKTETKLMTP | 276 | Q6ZNC4 | |
| MVNSCITSPSTPSKK | 621 | Q86T82 | |
| AKMEEKLSNPPATCT | 461 | Q6NXT6 | |
| LTSASCPSSLPMKRE | 111 | O14948 | |
| TGCLSSVPQMKKIST | 1101 | Q9Y4E6 | |
| KSCSATMSKPAPLNT | 1361 | Q5VUA4 | |
| AMTASEKTRSCKHPP | 311 | Q9H0E7 | |
| ESPGKSFQPITMSCK | 446 | Q9ULM3 | |
| MTHCSPQKTSPLTKI | 381 | Q96C45 | |
| PTSPASVTCKMGATV | 1651 | E9PAV3 |